Vuélvete ilimitado con Magzter GOLD
Obtenga acceso ilimitado a más de 9000 revistas, periódicos e historias Premium por solo
Intentar ORO - Gratis
Vaccines, anti-cancer drugs may soon carry QR codes
Mint Mumbai
|October 20, 2025
The move aims to make product-level traceability mandatory for four critical drug categories
The government aims to protect patients from counterfeit and substandard medicines.
(AP)
India is set to tighten rules on the sale and distribution of four crucial lifesaving medicine categories—vaccines, antimicrobials, narcotic and psychotropic drugs, and anticancer drugs—to safeguard public health, according to two government officials aware of the matter and documents reviewed by Mint.
As part of the plan, the government has proposed a major overhaul aimed at securing the pharmaceutical supply chain and protecting patients from counterfeit and substandard medicines.
This revamp involves inserting a new section under Schedule H2 of the Drugs and Cosmetics Rules, 1945, which currently requires certain drug formulations to carry a bar code or quick response (QR) code on their packaging. The move aims to make product-level traceability mandatory for these four critical drug categories.
Esta historia es de la edición October 20, 2025 de Mint Mumbai.
Suscríbete a Magzter GOLD para acceder a miles de historias premium seleccionadas y a más de 9000 revistas y periódicos.
¿Ya eres suscriptor? Iniciar sesión
MÁS HISTORIAS DE Mint Mumbai
Mint Mumbai
Spring cleaning: Time to declutter your financial cobwebs this Diwali
Tidy up your portfolio, loans and insurance, ensuring coverage is comprehensive for a stronger financial base
5 mins
October 20, 2025
Mint Mumbai
Jaiprakash insolvency nears final vote, CoC to review bids
CoC to evaluate how five bidders, including Vedanta and Adani, will finance the acquisition
3 mins
October 20, 2025
Mint Mumbai
Avaada to raise ₹10,000 cr via IPO, makes confidential filing
Avaada Electro, the solar module and cell manufacturing arm of Avaada Group, backed by Thailand’s PTT Group and Brookfield, has sought to raise ₹10,000 crore from an initial public offering (IPO), said two people aware of the development.
2 mins
October 20, 2025
Mint Mumbai
Why are Nobel literature winners often so unreadable?
I was reading Laszl6 Krasznahorkai and I thought early humans must have invented entertainment to escape from that feeling.
4 mins
October 20, 2025
Mint Mumbai
Can insurers reject ported policy claims?
I have been continuously insured under a health policy since 2020 and recently ported my plan to another insurer without any break in coverage.
2 mins
October 20, 2025
Mint Mumbai
RESOURCE NATIONALISM DEBATE PITS TALENT VERSUS MINERALS
The last quarter of the year is the season of the returning Indian diaspora; the weather starts getting better on the subcontinent just as it starts to get colder elsewhere.
3 mins
October 20, 2025
Mint Mumbai
The question of our times: Does economics promote inequality?
The disciplines emphasis on self-interest as rational’ must yield to a focus on global collaboration to achieve collective goals
3 mins
October 20, 2025
Mint Mumbai
Foreign banks eye India after RBL deal
Emirates NBD Bank's decision to buy a controlling stake in RBL Bank for $3 billion is likely to see more global banks looking at having an India play. With the banking regulator likely to allow such transactions going forward, a floodgate of more such transactions will open up, say bankers and industry experts.
1 mins
October 20, 2025
Mint Mumbai
Meesho gets Sebi nod for ₹6,600-cr IPO
Meesho has received regulatory approval for its ₹6,600-crore initial public offering, in which early investors including Elevation Capital and Peak XV Partners are expected to sell part of their stakes.
2 mins
October 20, 2025
Mint Mumbai
Vaccines, anti-cancer drugs may soon carry QR codes
The move aims to make product-level traceability mandatory for four critical drug categories
2 mins
October 20, 2025
Listen
Translate
Change font size